Ischemic preconditioning effect of prodromal angina is attenuated in acute myocardial infarction patients with hypertensive left ventricular hypertrophy

Circulation Journal

Volumn 75, Issue 5, 2011, Pages 1192-1199

  Takeuchi, Toshiharu ^a   Ishii, Yoshinao ^b   Kikuchi, Kenjiro ^a   Hasebe, Naoyuki ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b ASAHIKAWA CITY HOSPITAL   (Japan)

Author keywords

Acute myocardial infarction; Hypertension; Left ventricular hypertrophy; Reperfusion

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; CORONARY REPERFUSION; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART PROTECTION; HEART VENTRICULOGRAPHY; HUMAN; HYPERTENSION; ISCHEMIC PRECONDITIONING; MAJOR CLINICAL STUDY; MALE; PRODROMAL ANGINA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ANGINA PECTORIS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79955689539     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0906     Document Type: Article

References (35)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
2. Ottani F, Galvani M, Ferrini D, Sorbello F, Limonetti P, Pantoli D, et al. Prodromal angina limits infarct size: A role for ischemic preconditioning. Circulation 1995; 91: 291-297.
3. Noda T, Minatoguchi S, Fujii K, Hori M, Ito T, Kanmatsuse K, et al. Evidence for the delayed effect in human ischemic preconditioning: Prospective multicenter study for preconditioning in acute myocardial infarction. J Am Coll Cardiol 1999; 34: 1966-1974.
4. Maruhashi T, Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, et al. Effect of prodromal angina pectoris on the infarct progression in patients with first ST-elevation acute myocardial infarction. Circ J 2010; 74: 1651-1657.
5. Przyklenk K, Li G, Whittaker P. No loss in the in vivo efficacy of ischemic preconditioning in middle-aged and old rabbits. J Am Coll Cardiol 2001; 38: 1741-1747.
6. del Valle HF, Lascano EC, Negroni JA. Ischemic preconditioning protection against stunning in conscious diabetic sheep: Role of glucose, insulin, sarcolemmal and mitochondrial KATP channels. Cardiovasc Res 2002; 55: 642-659.
7. Ueda Y, Kitakaze M, Komamura K, Minamino T, Asanuma H, Sato H, et al. Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction. J Am Coll Cardiol 1999; 34: 2120-2125.
8. Ishihara M, Sato H, Tateishi H, Kawagoe T, Shimatani Y, Ueda K, et al. Beneficial effect of prodromal angina pectoris is lost in elderly patients with acute myocardial infarction. Am Heart J 2000; 139: 881-888.
9. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, et al. Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. J Am Coll Cardiol 2001; 38: 1007-1011.
10. Bolognese L, Dellavesa P, Rossi L, Sarasso G, Bongo AS, Scianaro MC. Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and one-vessel coronary artery disease. Am J Cardiol 1994; 73: 1-5.
11. Rabkin SW, Mathewson FA, Tate RB. Prognosis after acute myocardial infarction: Relation to blood pressure values before infarction in a prospective cardiovascular study. Am J Cardiol 1977; 40: 604-610.
12. Speechly-Dick ME, Baxter GF, Yellon DM. Ischaemic preconditioning protects hypertrophied myocardium. Cardiovasc Res 1994; 28: 1025-1029.
13. Boutros A, Wang J. Ischemic preconditioning, adenosine and bethanechol protect spontaneously hypertensive isolated rat hearts. J Pharmacol Exp Ther 1995; 275: 1148-1156.
14. Randall MD, Gardiner SM, Bennett T. Enhanced cardiac preconditioning in the isolated heart of the transgenic ((mREN-2) 27) hypertensive rat. Cardiovasc Res 1997; 33: 400-409.
15. Moolman JA, Genade S, Tromp E, Opie LH, Lochner A. Ischaemic preconditioning does not protect hypertrophied myocardium against ischaemia. S Afr Med J 1997; 87(Suppl 3): C151-C156.
16. Ebrahim Z, Yellon DM, Baxter GF. Ischemic preconditioning is lost in aging hypertensive rat heart: Independent effects of aging and longstanding hypertension. Exp Gerontol 2007; 42: 807-814.
17. Murakami J, Toyama T, Adachi H, Hoshizaki H, Oshima S, Kurabayashi M. Important factors for salvaging myocardium in patients with acute myocardial infarction. J Cardiol 2008; 52: 269-275.
18. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
19. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618.
20. van't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade: Zwolle Myocardial Infarction Study Group. Circulation 1998; 97: 2302-2306.
21. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
22. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Bartoccini C, et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol 1995; 25: 871-878.
23. Ueshima K, Yasuno S, Oba K, Fujimoto A, Ogihara T, Saruta T, et al. Effects of cardiac complications on cardiovascular events in Japanese high-risk hypertensive patients: Subanalysis of the CASE-J trial. Circ J 2009; 73: 1080-1085.
24. Hasebe N, Shen YT, Kiuchi K, Hittinger L, Bishop SP, Vatner SF. Enhanced postischemic dysfunction selective to subendocardium in conscious dogs with LV hypertrophy. Am J Physiol 1994; 266: H702-H713.
25. Koyanagi S, Eastham CL, Harrison DG, Marcus ML. Increased size of myocardial infarction in dogs with chronic hypertension and left ventricular hypertrophy. Circ Res 1982; 50: 55-62.
26. Houghton JL, Davison CA, Kuhner PA, Torossov MT, Strogatz DS, Carr AA. Heterogeneous vasomotor responses of coronary conduit and resistance vessels in hypertension. J Am Coll Cardiol 1998; 31:374-382.
27. Colonna P, Cadeddu C, Montisci R, Ruscazio M, Selem AH, Chen L. Reduced microvascular and myocardial damage in patients with acute myocardial infarction and preinfarction angina. Am Heart J 2002; 144: 796-803.
28. Takahashi T, Anzai T, Yoshikawa T, Maekawa Y, Asakura Y, Satoh T, et al. Effect of preinfarction angina pectoris on ST-segment resolution after primary coronary angioplasty for acute myocardial infarction. Am J Cardiol 2002; 90: 465-469.
29. Tamura A, Shinozaki K, Watanabe T, Nakaishi T, Nagase K, Kadota J. Effect of preinfarction angina pectoris on myocardial blush grade after reperfusion in first anterior wall acute myocardial infarction. Circ J 2006; 70: 698-702.
30. Hasebe N, Shen YT, Vatner SF. Inhibition of endothelium-derived relaxing factor enhances myocardial stunning in conscious dogs. Circulation 1993; 88: 2862-2871.
31. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Hata T, et al. Comparison of the cardioprotective effect of prodromal angina pectoris and collateral circulation in patients with a first anterior wall acute myocardial infarction. Am J Cardiol 2005; 95: 622-625.
32. Kyriakides ZS, Kremastinos DT, Michelakakis NA, Matsakas EP, Demovelis T, Toutouzas PK. Coronary collateral circulation in coronary artery disease and systemic hypertension. Am J Cardiol 1991; 67: 687-690.
33. Butler KL, Huffman LC, Koch SE, Hahn HS, Gwathmey JK. STAT-3 activation is necessary for ischemic preconditioning in hypertrophied myocardium. Am J Physiol Heart Circ Physiol 2006; 291: H797-H803.
34. Yasukawa H, Hoshijima M, Gu Y, Nakamura T, Pradervand S, Hanada T, et al. Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways. J Clin Invest 2001; 108: 1459-1467.
35. Rogers WJ, McDaniel HG, Smith LR, Mantle JA, Russel RO Jr, Rackley CE. Correlation of angiographic estimates of myocardial infarct size and accumulated release of creatine kinase MB isoenzyme in man. Circulation 1977; 56: 199-205.